Overall, significant bone marrow invasion by leukaemic blasts (≥ 25% CD45+CD7+ cells) was observed in 70% (28/40) of mice transplanted with MEKi-treated T-ALL cells compared to 27% (12/44) of animals injected with untreated cells (Fig 1C). This evidence concerns the gene PTPRC and acute lymphoblastic leukemia.